These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4890200)

  • 1. Tay-sachs disease. Demonstration of the stored ganglioside in cultured cells from brain biopsy.
    Batzdorf U; Sarlieve LL; Gold VA; Menkes JH
    Arch Neurol; 1969 Jun; 20(6):650-2. PubMed ID: 4890200
    [No Abstract]   [Full Text] [Related]  

  • 2. The metabolism of Tay-Sachs ganglioside: catabolic studies with lysosomal enzymes from normal and Tay-Sachs brain tissue.
    Tallman JF; Johnson WG; Brady RO
    J Clin Invest; 1972 Sep; 51(9):2339-45. PubMed ID: 4639018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of an alteration of ganglioside metabolism in Tay-Sachs disease.
    Kolodny EH; Brady RO; Volk BW
    Biochem Biophys Res Commun; 1969 Oct; 37(3):526-31. PubMed ID: 5388728
    [No Abstract]   [Full Text] [Related]  

  • 4. Abnormal gangliosides in Tay-Sachs disease, Niemann-Pick's disease, and gargoylism.
    Booth DA; Goodwin H; Cumings JN
    J Lipid Res; 1966 May; 7(3):337-40. PubMed ID: 4959256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infantile type of so-called neuronal ceroid-lipofuscinosis. 2. Morphological and biochemical studies.
    Haltia M; Rapola J; Santavuori P; Keränen A
    J Neurol Sci; 1973 Mar; 18(3):269-85. PubMed ID: 4121459
    [No Abstract]   [Full Text] [Related]  

  • 6. Electron histochemical demonstration of gangliosides in normal and Tay-Sachs brain tissue.
    Halaris A; Jatzkewitz H
    Acta Neuropathol; 1969; 13(2):157-68. PubMed ID: 4185163
    [No Abstract]   [Full Text] [Related]  

  • 7. Tay-sachs disease.
    Brady RO
    N Engl J Med; 1969 Nov; 281(22):1243-4. PubMed ID: 5347842
    [No Abstract]   [Full Text] [Related]  

  • 8. Preparation of radioactive Tay-Sachs ganglioside labeled in the sialic acid moiety.
    Kolodny EH; Brady RO; Quirk JM; Kanfer JN
    J Lipid Res; 1970 Mar; 11(2):144-9. PubMed ID: 5418476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Concerning brain gangliosides in Tay-Sachs disease].
    Wagner A
    Klin Wochenschr; 1966 Apr; 44(7):398-402. PubMed ID: 5983851
    [No Abstract]   [Full Text] [Related]  

  • 10. Generalized accumulation of neutral glycosphingolipids with G M2 ganglioside accumulation in the brain.
    Snyder PD; Krivit W; Sweeley CC
    J Lipid Res; 1972 Jan; 13(1):128-36. PubMed ID: 5059190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fine structure of fetal Tay-Sachs disease.
    Adachi M; Torii J; Schneck L; Volk BW
    Arch Pathol; 1971 Jan; 91(1):48-54. PubMed ID: 4922628
    [No Abstract]   [Full Text] [Related]  

  • 12. Gm1-gangliosidosis and juvenile cerebral lipidosis. Clinical, histochemical, and chemical study.
    Patton VM; Dekaban AS
    Arch Neurol; 1971 Jun; 24(6):529-37. PubMed ID: 5089899
    [No Abstract]   [Full Text] [Related]  

  • 13. Generalized accumulation of neutral glycosphingolipids with GM2 ganglioside accumulation in the brain. Sandhoff's disease (variant of Tay-Sachs disease).
    Krivit W; Desnick RJ; Lee J; Moller J; Wright F; Sweeley CC; Snyder PD; Sharp HL
    Am J Med; 1972 Jun; 52(6):763-70. PubMed ID: 5030173
    [No Abstract]   [Full Text] [Related]  

  • 14. The catabolism of Tay-Sachs ganglioside in rat brain lysosomes.
    Tallman JF; Brady RO
    J Biol Chem; 1972 Dec; 247(23):7570-5. PubMed ID: 4636324
    [No Abstract]   [Full Text] [Related]  

  • 15. Asialo GM-ganglioside in brain fetal Tay-Sachs disease.
    Schneck L; Pinkett B; Volk BW
    J Neurochem; 1975 Jan; 24(1):183-4. PubMed ID: 1110360
    [No Abstract]   [Full Text] [Related]  

  • 16. Gangliosidosis with total hexosaminidase deficiency: clinical, biochemical and ultrastructural studies and comparison with conventional cases of Tay-Sachs disease.
    Fontaine G; Résibois A; Tondeur M; Jonniaux G; Farriaux JP; Voet W; Maillard E; Loeb H
    Acta Neuropathol; 1973 Jan; 23(2):118-32. PubMed ID: 4349527
    [No Abstract]   [Full Text] [Related]  

  • 17. GM1-gangliosidosis (gneralized gangliosidosis). Morphology and chemical pathology.
    Suzuki K; Chen GC
    Pathol Eur; 1968; 3(2):389-408. PubMed ID: 5688472
    [No Abstract]   [Full Text] [Related]  

  • 18. [On a component of the mixture of brain gangliosides, which is transferred to the Tay-Sachs ganglioside under the influence of neuraminidase].
    Klenk E; Naoi M
    Hoppe Seylers Z Physiol Chem; 1968 Mar; 349(3):288-92. PubMed ID: 4302220
    [No Abstract]   [Full Text] [Related]  

  • 19. Juvenile GM2 gangliosidosis. Biochemical and ultrastructural studies on a new variant of Tay-Sachs disease.
    Menkes JH; O'Brien JS; Okada S; Grippo J; Andrews JM; Cancilla PA
    Arch Neurol; 1971 Jul; 25(1):14-22. PubMed ID: 5146406
    [No Abstract]   [Full Text] [Related]  

  • 20. GM1-ganglioside accumulation and beta-galactosidase deficiency in a case of GM1-gangliosidosis (Landing disease).
    Dacremont G; Kint JA
    Clin Chim Acta; 1968 Sep; 21(3):421-5. PubMed ID: 5725200
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.